Skip to main content

Table 2 Proportion of complete absorption of macular SRF, change in BCVA, and number of treatment over the 12-month period both the STMP group and the half-dose PDT group

From: Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy

STMP Group

Half-dose PDT Group

P value

 

Variables

(n = 18)

(n = 21)

 

Complete absorption of

macular SRF at month 12,

 (n)

15(83.3%)

19(90.5%)

0.647

Change in BCVA at month 12,

(n), (ETDRS)

 Gained ≥ 15 letters

6 (33.3%)

8(38.1%)

0.757

 Gained ≥ 5 letters

15(83.3%)

19(90.5%)

 

 No change

3(16.7%)

2(9.5%)

0.506

 Lost ≥ 5 letters

0

0

 

Number of treatment over

the 12-month period, (n)

 1

11

17

 

 2

5

3

 

 3

0

0

 

 4

2

1

0.174

  1. SRF subretinal fluid, BCVA best-corrected visual acuity, STMP subthreshold micropulse, PDT photodynamic therapy, ETDRS Early Treatment Diabetic Retinopathy Study